LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 80 filers reported holding LYELL IMMUNOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,116,528 | +690.4% | 759,543 | +1609.8% | 0.00% | – |
| Q2 2023 | $141,268 | -5.6% | 44,424 | -30.0% | 0.00% | – |
| Q1 2023 | $149,676 | +98.1% | 63,422 | +191.3% | 0.00% | – |
| Q4 2022 | $75,556 | -94.3% | 21,774 | -91.7% | 0.00% | – |
| Q1 2022 | $1,320,000 | -52.3% | 261,238 | -27.0% | 0.00% | -100.0% |
| Q4 2021 | $2,770,000 | -0.3% | 357,894 | +90.6% | 0.00% | 0.0% |
| Q3 2021 | $2,778,000 | -47.9% | 187,729 | -42.8% | 0.00% | 0.0% |
| Q2 2021 | $5,327,000 | – | 328,033 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $131,458,000 | 59.13% |
| Apoletto Ltd | 15,093,969 | $98,413,000 | 27.22% |
| Foresite Capital Management IV, LLC | 13,282,181 | $86,600,000 | 23.32% |
| MIC Capital Management UK LLP | 3,060,569 | $19,955,000 | 3.90% |
| Alphabet Inc. | 5,865,125 | $38,241,000 | 2.08% |
| HSG Holding Ltd | 3,045,997 | $19,860,000 | 1.83% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $10,744,000 | 0.72% |
| SG3 Management, LLC | 600,000 | $3,912,000 | 0.46% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 157,700 | $1,028,000 | 0.26% |
| Artal Group S.A. | 700,000 | $4,564,000 | 0.24% |